For cardiometabolic outcomes, EX + IF reduced total cholesterol, triglycerides, low-density lipoprotein cholesterol, and interleukin-6; improved fasting blood glucose, fasting insulin, and homeostasis model assessment of insulin resistance (HOMA-IR); and modestly increased VO<sub>2</sub>max. The gene discussed is INS; the disease is Insulin resistance.